Science

Current therapies for Parkinson’s disease and related conditions primarily treat symptoms but don’t stop the underlying process causing the disease.

Increasing evidence suggests that toxic clumps of proteins called alpha-synuclein are among the primary drivers of damage to neurons. My team and I developed a synthetic molecule that can block these proteins from clumping and spreading in the brains of mice, ultimately reducing symptoms of disease.

This article was written by Rosemary Trout, an associate clinical professor of culinary arts and food science at Drexel University, for The Conversation — a nonprofit news organization dedicated to sharing the knowledge of researchers and scientists, under a Creative Commons license. Read the original article here. My mother loves butter. It is the primary

Benjamin Franklin understood something fundamental about money that still shapes modern economies: Money only works when people believe it is real.

Hollywood loves a superpower. Not all involve capes or cosmic rays. Some are cognitive: characters who can remember everything. In movies and on TV, viewers repeatedly encounter those with extraordinary minds who glance once at a page, a room or a face – and later recreate every detail with surgical precision.

As the weather grows cold this winter, you may be one of the many Americans pulling their winter jackets out of the closet. Not only can this extra layer keep you warm on a chilly day, but modern winter jackets are also a testament to centuries-old physics and cutting-edge materials science.